Advertisement

Search Results

Advertisement



Your search for Syed Ali Abutalib, MD and Saad Z. Usmani, MD, FACP,Syed Ali Abutalib, MD and Saad Z. Usmani, MD, FACP matches 3 pages

Showing 1 - 3


multiple myeloma

Bispecific Antibodies and the Dawn of a New Era in Treatment of Multiple Myeloma

“I think the biggest innovations of the 21st century will be at the intersection of biology and technology. A new era is beginning!”  —Steve Jobs Relapsed and refractory multiple myeloma remains a treatment challenge. Promising responses have been demonstrated with bispecific antibodies, with a...

multiple myeloma
immunotherapy

High-Risk Multiple Myeloma: Combination Regimens and CAR T-Cell Therapy

“Continuous improvement is better than delayed perfection.”  —Mark Twain To complement The ASCO Post’s extensive coverage of the 2021 ASCO Annual Meeting, here are several abstracts selected from the meeting proceedings focusing on novel treatments under study in high-risk multiple myeloma. For...

hematologic malignancies
covid-19

Cancer and COVID-19: Considerations About Neutropenia, Anemia, and Thrombocytopenia

GUEST EDITORS Dr. Abutalib is Associate Director of the Hematology and Cellular Therapy Program and Director of the Clinical Apheresis Program at Cancer Treatment Centers of America, Zion, Illinois; Associate Professor at the Roseland Franklin University of Medicine and Science; and Founder and...

Advertisement

Advertisement




Advertisement